| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |